Ipamorelin — Growth Hormone & Ghrelin Receptor Signaling Research
A synthetic growth hormone secretagogue studied around the biology of pituitary growth hormone release, ghrelin-receptor signaling, and neuroendocrine communication, with particular interest in the pathways regulating pulsatile growth hormone secretion.
Ipamorelin is a pentapeptide that acts as an agonist of the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor. Research has explored its relationship with growth hormone secretion, pituitary signaling, ghrelin-associated pathways, and the GH/IGF-1 axis. Ipamorelin is often distinguished experimentally from some earlier growth hormone-releasing peptides because of its receptor activity and endocrine profile. It is not an FDA-approved medication.
Research Focus: Ghrelin Receptor (GHS-R1a) • Growth Hormone Signaling • Pituitary Function • GH/IGF-1 Axis • Hormonal Pulsatility • Neuroendocrine Communication • Endocrine Research
A growth hormone secretagogue research peptide for those interested in the science of ghrelin-receptor biology, pituitary communication, growth hormone signaling, and the endocrine pathways involved in the GH/IGF-1 axis.
Educational Disclaimer
This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.
Ipamorelin — Growth Hormone & Ghrelin Receptor Signaling Research
A synthetic growth hormone secretagogue studied around the biology of pituitary growth hormone release, ghrelin-receptor signaling, and neuroendocrine communication, with particular interest in the pathways regulating pulsatile growth hormone secretion.
Ipamorelin is a pentapeptide that acts as an agonist of the growth hormone secretagogue receptor (GHS-R1a), also known as the ghrelin receptor. Research has explored its relationship with growth hormone secretion, pituitary signaling, ghrelin-associated pathways, and the GH/IGF-1 axis. Ipamorelin is often distinguished experimentally from some earlier growth hormone-releasing peptides because of its receptor activity and endocrine profile. It is not an FDA-approved medication.
Research Focus: Ghrelin Receptor (GHS-R1a) • Growth Hormone Signaling • Pituitary Function • GH/IGF-1 Axis • Hormonal Pulsatility • Neuroendocrine Communication • Endocrine Research
A growth hormone secretagogue research peptide for those interested in the science of ghrelin-receptor biology, pituitary communication, growth hormone signaling, and the endocrine pathways involved in the GH/IGF-1 axis.
Educational Disclaimer
This information is provided for educational purposes regarding the biological and scientific research associated with the ingredients listed. It is not intended to diagnose, treat, cure, or prevent disease or to provide individualized medical advice.